Androgen receptor agonists as breast cancer therapeutics
Nat Med
.
2021 Feb;27(2):198-199.
doi: 10.1038/s41591-021-01242-8.
Authors
Jennifer L Caswell-Jin
1
,
Christina Curtis
2
3
4
Affiliations
1
Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. caswell@stanford.edu.
2
Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.
3
Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.
4
Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.
PMID:
33558723
DOI:
10.1038/s41591-021-01242-8
No abstract available
Publication types
Comment
MeSH terms
Androgens
Breast Neoplasms* / drug therapy
Humans
Receptors, Androgen* / genetics
Receptors, Estrogen
Signal Transduction
Substances
Androgens
Receptors, Androgen
Receptors, Estrogen